Currently, out of the existing stock ratings of Jonathan Aschoff - 88 which are a Buy (87.13%), 8 which are a Hold (7.92%), 5 which are a Sell (4.95%)

Jonathan Aschoff

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Aschoff works at ROTH and is covering the Healthcare sector with 175 price targets and ratings displayed on 24 stocks. Previously, Jonathan Aschoff worked at BREAN.

Jonathan Aschoff's average stock forecast success ratio is 36.96% with an average time for price targets to be met of 101.17 days.

Most recent stock forecast was given on FWBI, at 19-Sep-2023.

Wall Street Analyst Jonathan Aschoff

Analyst best performing recommendations are on MBRX.
The best stock recommendation documented was for MBRX at 2/1/2021. The price target of $5 was fulfilled within 1 day with a profit of $0.3 (6.38%) receiving and performance score of 63.83.

Average potential price target upside

of $651 (33.83%) on FWBI.
of $41.54 (7.64%) on REGN (REGENERON PHARMACEUTICALS).
of $9.3 (46.32%) on CLRB.

ALXN APDN Applied DNA Sciences APVO INCY yte INO Inovio Pharmaceuticals MBRX SEEL TFFP TFF Pharmaceuticals VVUS CLDX Celldex Therapeutics PGNX REGN Regeneron Pharmaceuticals AZRX CMRX Chimerix BPTH FWBI NOVN REVB KMPH AKBA Akebia Therapeutics BFRI CLRB HRTX Heron Therapeutics ACER Acer Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Geoffrey Porges (LEERINK)